Not Applicablecorporatehealthcare
Pharma Brand Name Extensions Under Scrutiny by CDSCO
The Directorate General of Health Services has invited comments on the use of brand name extensions in pharma, potentially signaling regulatory changes that could affect marketing strategies of pharmaceutical companies.
Jul 14, 2026Read more →
